Acadia Healthcare Files 8-K
Ticker: ACHC · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1520697
| Field | Detail |
|---|---|
| Company | Acadia Healthcare Company, Inc. (ACHC) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations
Related Tickers: ACHC
TL;DR
Acadia Healthcare (ACHC) filed an 8-K on Jan 13, 2025, reporting financial results.
AI Summary
On January 13, 2025, Acadia Healthcare Company, Inc. filed an 8-K report detailing results of operations and financial condition. The filing does not contain specific financial figures or operational updates beyond the reporting date itself.
Why It Matters
This 8-K filing indicates Acadia Healthcare is reporting on its financial condition and operational results as of January 13, 2025.
Risk Assessment
Risk Level: low — This is a routine filing reporting on financial condition and results of operations, without immediate new material information.
Key Players & Entities
- Acadia Healthcare Company, Inc. (company) — Registrant
- January 13, 2025 (date) — Report Date
FAQ
What is the primary purpose of this 8-K filing for Acadia Healthcare Company, Inc.?
The primary purpose of this 8-K filing is to report on the results of operations and financial condition of Acadia Healthcare Company, Inc. as of January 13, 2025.
What is the filing date of this 8-K report?
The 8-K report was filed on January 13, 2025.
What is the principal executive office address for Acadia Healthcare Company, Inc.?
The principal executive offices are located at 6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067.
What is the telephone number for Acadia Healthcare Company, Inc.?
The telephone number is (615) 861-6000.
What is the state of incorporation for Acadia Healthcare Company, Inc.?
Acadia Healthcare Company, Inc. is incorporated in Delaware.
Filing Stats: 436 words · 2 min read · ~1 pages · Grade level 11.6 · Accepted 2025-01-13 08:02:04
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value ACHC NASDAQ Global Select
Filing Documents
- d915447d8k.htm (8-K) — 22KB
- 0001193125-25-005003.txt ( ) — 140KB
- achc-20250113.xsd (EX-101.SCH) — 3KB
- achc-20250113_lab.xml (EX-101.LAB) — 18KB
- achc-20250113_pre.xml (EX-101.PRE) — 11KB
- d915447d8k_htm.xml (XML) — 4KB
From the Filing
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 13, 2025 Acadia Healthcare Company, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35331 45-2492228 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 6100 Tower Circle , Suite 1000 Franklin , Tennessee 37067 (Address of Principal Executive Offices) (Zip Code) (615) 861-6000 (Registrant's Telephone Number, including Area Code) Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.01 par value ACHC NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item2.02 Results of Operations and Financial Condition. Members of the senior management team of Acadia Healthcare Company, Inc. (the "Company") are scheduled to meet with investors at the J.P. Morgan Healthcare Conference during the week of January 13, 2025. In conjunction with these meetings, the Company today announced that same-facility patient days for the three months ended December 31, 2024 grew 3.2% on a year-over-year basis, within the expected range that was previously communicated on October 31, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 13, 2025 ACADIA HEALTHCARE COMPANY, INC. By: /s/ Brian P. Farley Brian P. Farley Executive Vice President, Secretary and General Counsel